Endocytosis is a critical step in entry of subgroup B avian leukosis viruses - PubMed (original) (raw)

Endocytosis is a critical step in entry of subgroup B avian leukosis viruses

Felipe Diaz-Griffero et al. J Virol. 2002 Dec.

Abstract

The avian leukosis virus (ALV) entry mechanism is controversial, with evidence for and against a low-pH requirement for viral fusion. To further address this question, we tested the entry of human immunodeficiency virus type 1 (HIV-1) pseudotyped with the envelope protein of subgroup B ALV (ALV-B) in the presence of three different lysosomotropic agents. These lysosomotropic agents were able to block the entry of wild-type and pseudotyped ALV-B in two different cell lines, strongly suggesting that ALV-B requires a low-pH step for entry. ALV-B and pH-dependent Semliki Forest virus (SFV) entered cells with slower uptake kinetics than HIV-1, which is pH independent. These slow uptake rates support the theory that ALV-B utilizes endocytic pathways to enter cells. Using immunofluorescence and electron microscopy analysis, we visualized the colocalization of virus particles with the endosomal marker transferrin and demonstrated virus particles in clathrin-coated vesicles and endosome-like structures. Surprisingly, a low-pH treatment did not overcome the inhibition of ALV-B entry by lysosomotropic agents. This indicates that, in contrast to SFV, ALV-B is unable to fuse at the cellular surface, even at a low pH. Taken together, our findings suggest that endocytosis and a subsequent low-pH step are critical for successful ALV-B infection.

PubMed Disclaimer

Figures

FIG. 1.

FIG. 1.

Entry assay of an HIV-1-based vector pseudotyped with the envelope protein of ALV-B. (A) Astrocytoma cells (U-251) and HEK 293 cells were stably transfected with TVBS3-expressing vector. Extracts from chicken embryonic fibroblasts (DF-1) and human cell lines transfected with or without TVBS3 were prepared, and 10 μg of protein was analyzed by Western blot analysis to detect TVBS3 expression. (B) HIV-1 vector (NLluc+env−) was pseudotyped with the envelope protein of ALV-B. Parental and HEK 293-TVBS3 cells were infected for 3 h with pseudotyped ALV-B viruses (10 ng of p24). Supernatant was removed and replaced with fresh medium, and luciferase activity was measured 48 h postinfection. (C) Parental and U-251-TVBS3 were infected with pseudotyped ALV-B (10 ng of p24) as described above for panel B. Experiments were performed in triplicates, and standard deviations are indicated for panels B and C.

FIG. 2.

FIG. 2.

Entry of wild-type and pseudotyped ALV-B is inhibited by lysosomotropic agents. HEK 293-TVBS3 cells were incubated with pseudotyped ALV-B, SFV, a-MLV, or HTLV-1 for 4 h in the presence or absence of 50 mM NH4Cl (A), 100 μg of chloroquine/ml (B), or 50 nM bafilomycin _A_1 (C). Cells were challenged with pseudotyped ALV-B, SFV, a-MLV, and HTLV-1 with similar amounts of p24.Luciferase activity was measured from cellular extracts 48 h postinfection. (D) HEK 293-TVBS3 cells were incubated with wild-type ALV-B that expresses GFP (MOI of 10) in the presence or absence of 50 mM NH4Cl, 100 μg of chloroquine/ml, or 50 nM of bafilomycin _A_1 for 4 h. Infection was determined by flow cytometry analysis by counting GFP-positive cells 72 h postinfection. Experiments were performed in triplicate, and standard deviations are indicated.

FIG. 3.

FIG. 3.

Entry kinetics of pseudotyped ALV-B. Pseudotyped ALV-B (10 ng of p24) was prebound to HEK 293-TVBS3 (A) or U-251-TVBS3 (B) cells at 4°C for 1 h. Infection was initiated by shifting the temperature to 37°C. At the indicated time point, cells were incubated for 2 to 3 h with 50 mM NH4Cl to stop viral entry. Subsequently, supernatants were replaced with fresh medium and luciferase activity was determined 48 h postinfection. Pseudotyped SFV was prebound to HEK 293-TVBS3 cells, and entry kinetics were determined as described above (C). Experiments were performed in triplicate, and standard deviations are shown.

FIG. 4.

FIG. 4.

Pseudotyped ALV-B particles colocalize with an endosomal marker. (A) Pseudotyped ALV-B particles (10 ng of p24) were prebound to U-251-TVBS3-3 cells, and infection was started by shifting cells to 37°C. Cells were processed for immunofluorescence, stained using the anti-p24 antibodies, and developed with a Cy3-labeled antibody (arrows). (B) Pseudotyped ALV-B and human transferrin-Alexa 488 (green) were prebound to U-251-TVBS3-3 cells at 4°C for 1 h. Viral infection and transferrin uptake were initiated by shifting the temperature to 37°C. After 30 min, cells were processed for immunofluorescence with an anti-p24 antibody and developed with a Cy3-labeled antibody (red). Z sections were obtained in both filters (Alexa 488 and Cy3) of a wide-field fluorescence microscope. Images were deconvolved as described in Materials and Methods. The 3-D projection of an infected cell (30 sections) was done in Imaris version 3.0, showing pseudotyped ALV-B particles (red), endosomes (green), and colocalization (yellow). (C) Individual Z sections are shown, and the distance from the cell surface is indicated in micrometers.

FIG. 4.

FIG. 4.

Pseudotyped ALV-B particles colocalize with an endosomal marker. (A) Pseudotyped ALV-B particles (10 ng of p24) were prebound to U-251-TVBS3-3 cells, and infection was started by shifting cells to 37°C. Cells were processed for immunofluorescence, stained using the anti-p24 antibodies, and developed with a Cy3-labeled antibody (arrows). (B) Pseudotyped ALV-B and human transferrin-Alexa 488 (green) were prebound to U-251-TVBS3-3 cells at 4°C for 1 h. Viral infection and transferrin uptake were initiated by shifting the temperature to 37°C. After 30 min, cells were processed for immunofluorescence with an anti-p24 antibody and developed with a Cy3-labeled antibody (red). Z sections were obtained in both filters (Alexa 488 and Cy3) of a wide-field fluorescence microscope. Images were deconvolved as described in Materials and Methods. The 3-D projection of an infected cell (30 sections) was done in Imaris version 3.0, showing pseudotyped ALV-B particles (red), endosomes (green), and colocalization (yellow). (C) Individual Z sections are shown, and the distance from the cell surface is indicated in micrometers.

FIG. 5.

FIG. 5.

Wild-type ALV-B is in clathrin-coated vesicles and endosome-like structures. Wild-type ALV-B viruses were prebound to DF-1 cells at 4°C for 1 h. Infection was initiated by shifting the temperature to 37°C. Thirty minutes after infection was initiated, samples were processed for ultrastructural analysis. Virus particles were observed (arrows) at a magnification of ×12,000 at the surface of DF-1 cells (A and B), in clathrin-coated vesicles (C and D), and in vesicles (E) while fusing to the vesicle membrane (F).

FIG. 6.

FIG. 6.

Entry of pseudotyped ALV-B is inhibited by chlorpromazine. HEK 293-TVB S3 cells were incubated with pseudotyped ALV-B, SFV, or a-MLV for 3 h in the presence or absence of 50 μM chlorpromazine. Cells were challenged with pseudotyped ALV-B, SFV, or a-MLV by using similar amounts of p24. Luciferase activity was measured from cellular extracts 48 h postinfection. Experiments were performed in triplicate, and standard deviations are shown.

FIG.7.

FIG.7.

Wild-type and pseudotyped ALV-B were unable to fuse at the cell surface upon low-pH treatment. Pseudotyped SFV (10 ng of p24) (A), pseudotyped ALV-B (10 ng of p24) (B), and wild-type ALV-B (MOI = 10) (C) were prebound to HEK 293-TVBS3 cells at 4°C for 1 h. Cells were treated with a medium, pH 5.3 or 7.0, for 2 min at 37°C. Subsequently, cells were incubated in fresh medium for 4 h in the presence or absence of 50 mM NH4Cl. Supernatants were replaced with fresh medium, and luciferase activity was measured 48 h postinfection (A and B). Flow cytometry analysis for GFP-positive cells was used to determine infection by wild-type ALV-B (C). Pseudotyped ALV-B (10 ng of p24) was prebound to HEK 293-TVBS3 cells at 4°C for 1 h. Cells were treated with a medium, pH 5.3, containing or lacking 50 mM NH4Cl for 5, 15, or 30 min at 37°C. Subsequently, cells were incubated with medium containing 50 mM NH4Cl for 4 h. Cells were grown in fresh medium, and extracts were prepared 48 h postinfection to measure luciferase activity (D). Experiments were performed in triplicate, and standard deviations are shown.

Similar articles

Cited by

References

    1. Adkins, H. B., J. Brojatsch, J. Naughton, M. M. Rolls, J. M. Pesola, and J. A. Young. 1997. Identification of a cellular receptor for subgroup E avian leukosis virus. Proc. Natl. Acad. Sci. USA 94:11617-11622. - PMC - PubMed
    1. Adkins, H. B., J. Brojatsch, and J. A. Young. 2000. Identification and characterization of a shared TNFR-related receptor for subgroup B, D, and E avian leukosis viruses reveal cysteine residues required specifically for subgroup E viral entry. J. Virol. 74:3572-3578. - PMC - PubMed
    1. Aiken, C. 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71:5871-5877. - PMC - PubMed
    1. Andersen, K. B. 1985. The fate of the surface protein gp70 during entry of retrovirus into mouse fibroblasts. Virology 142:112-120. - PubMed
    1. Andersen, K. B., and B. A. Nexo. 1983. Entry of murine retrovirus into mouse fibroblasts. Virology 125:85-98. - PubMed

MeSH terms

Substances

LinkOut - more resources